Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Oct 1;98(7):1585–1593. doi: 10.1172/JCI118952

An in vitro assay for detection of glomerular binding IgG autoantibodies in patients with systemic lupus erythematosus.

L Budhai 1, K Oh 1, A Davidson 1
PMCID: PMC507591  PMID: 8833907

Abstract

The deposition of anti-dsDNA antibodies in the glomerulus is believed to play a critical role in the pathogenesis of nephritis in SLE. However, an absolute correlation between serum levels of anti-dsDNA antibodies and renal disease has not been found. Recently a glomerular binding assay (GBA) has been developed to detect IgG binding to isolated rat glomeruli. We have used the GBA to study sera from four groups of SLE patients: (A) + anti-dsDNA antibodies, active nephritis; (B) - anti-dsDNA antibodies, active nephritis; (C) + anti-dsDNA antibodies, no nephritis; and (D) - anti-dsDNA antibodies, no nephritis. The serum anti-dsDNA antibodies in group A and group C patients could not be distinguished on the basis of isotype, charge, or cross-reactivity with histones. Nevertheless, the mean intensity of glomerular immunofluorescence was significantly higher in group A than in the three other patient groups and distinguished between patients with serum anti-dsDNA antibodies who had nephritis and those without clinically apparent nephritis. GBA reactivity was unaffected by DNase treatment of sera, but was partially inhibited by preincubation with dsDNA. These findings are consistent with the hypothesis that some anti-dsDNA antibodies cross-react with glomerular components and that the presence of this cross-reactivity is associated with, and may be responsible for, the development of nephritis. In addition, we have identified a group of SLE patients with renal disease and typical renal histopathology and immune deposits who do not have serum anti-dsDNA antibodies or antibodies that directly bind to glomeruli in the GBA. The mechanism of renal immune deposition in these patients remains to be determined.

Full Text

The Full Text of this article is available as a PDF (401.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernstein K. A., Bolshoun D., Lefkowith J. B. Serum glomerular binding activity is highly correlated with renal disease in MRL/lpr mice. Clin Exp Immunol. 1993 Sep;93(3):418–423. doi: 10.1111/j.1365-2249.1993.tb08194.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bernstein K. A., Kahl L. E., Balow J. E., Lefkowith J. B. Serologic markers of lupus nephritis in patients: use of a tissue-based ELISA and evidence for immunopathogenic heterogeneity. Clin Exp Immunol. 1994 Oct;98(1):60–65. doi: 10.1111/j.1365-2249.1994.tb06607.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bernstein K. A., Valerio R. D., Lefkowith J. B. Glomerular binding activity in MRL lpr serum consists of antibodies that bind to a DNA/histone/type IV collagen complex. J Immunol. 1995 Mar 1;154(5):2424–2433. [PubMed] [Google Scholar]
  4. Davidson A., Lopez J., Sun D., Prus D. A monoclonal anti-idiotype specific for human polyclonal IgM rheumatoid factor. J Immunol. 1992 Jun 15;148(12):3873–3878. [PubMed] [Google Scholar]
  5. Di Valerio R., Bernstein K. A., Varghese E., Lefkowith J. B. Murine lupus glomerulotropic monoclonal antibodies exhibit differing specificities but bind via a common mechanism. J Immunol. 1995 Aug 15;155(4):2258–2268. [PubMed] [Google Scholar]
  6. Foster M. H., Cizman B., Madaio M. P. Nephritogenic autoantibodies in systemic lupus erythematosus: immunochemical properties, mechanisms of immune deposition, and genetic origins. Lab Invest. 1993 Nov;69(5):494–507. [PubMed] [Google Scholar]
  7. Golbus J., McCune W. J. Lupus nephritis. Classification, prognosis, immunopathogenesis, and treatment. Rheum Dis Clin North Am. 1994 Feb;20(1):213–242. [PubMed] [Google Scholar]
  8. Guzmán J., Cardiel M. H., Arce-Salinas A., Sánchez-Guerrero J., Alarcón-Segovia D. Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol. 1992 Oct;19(10):1551–1558. [PubMed] [Google Scholar]
  9. Halpern R., Davidson A., Lazo A., Solomon G., Lahita R., Diamond B. Familial systemic lupus erythematosus. Presence of a cross-reactive idiotype in healthy family members. J Clin Invest. 1985 Aug;76(2):731–736. doi: 10.1172/JCI112028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Halpern R., Schiffenbauer J., Solomon G., Diamond B. Detection of masked anti-DNA antibodies in lupus sera by a monoclonal anti-idiotype. J Immunol. 1984 Oct;133(4):1852–1856. [PubMed] [Google Scholar]
  11. Isenberg D. A., Collins C. Detection of cross-reactive anti-DNA antibody idiotypes on renal tissue-bound immunoglobulins from lupus patients. J Clin Invest. 1985 Jul;76(1):287–294. doi: 10.1172/JCI111959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Madaio M. P., Carlson J., Cataldo J., Ucci A., Migliorini P., Pankewycz O. Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits. J Immunol. 1987 May 1;138(9):2883–2889. [PubMed] [Google Scholar]
  13. Miyazaki M., Endoh M., Suga T., Yano N., Kuramoto T., Matsumoto Y., Eguchi K., Yagame M., Miura M., Nomoto Y. Rheumatoid factors and glomerulonephritis. Clin Exp Immunol. 1990 Aug;81(2):250–255. doi: 10.1111/j.1365-2249.1990.tb03326.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Petri M., Genovese M., Engle E., Hochberg M. Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum. 1991 Aug;34(8):937–944. doi: 10.1002/art.1780340802. [DOI] [PubMed] [Google Scholar]
  15. Raz E., Brezis M., Rosenmann E., Eilat D. Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. J Immunol. 1989 May 1;142(9):3076–3082. [PubMed] [Google Scholar]
  16. Sasaki T., Hatakeyama A., Shibata S., Osaki H., Suzuki M., Horie K., Kitagawa Y., Yoshinaga K. Heterogeneity of immune complex-derived anti-DNA antibodies associated with lupus nephritis. Kidney Int. 1991 Apr;39(4):746–753. doi: 10.1038/ki.1991.91. [DOI] [PubMed] [Google Scholar]
  17. Sasaki T., Muryoi T., Hatakeyama A., Suzuki M., Sato H., Seino J., Saito T., Yoshinaga K. Circulating anti-DNA immune complexes in active lupus nephritis. Am J Med. 1991 Oct;91(4):355–362. doi: 10.1016/0002-9343(91)90152-n. [DOI] [PubMed] [Google Scholar]
  18. Siegert C. E., Daha M. R., Tseng C. M., Coremans I. E., van Es L. A., Breedveld F. C. Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus. Ann Rheum Dis. 1993 Dec;52(12):851–856. doi: 10.1136/ard.52.12.851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Swanson P. C., Yung R. L., Blatt N. B., Eagan M. A., Norris J. M., Richardson B. C., Johnson K. J., Glick G. D. Ligand recognition by murine anti-DNA autoantibodies. II. Genetic analysis and pathogenicity. J Clin Invest. 1996 Apr 1;97(7):1748–1760. doi: 10.1172/JCI118602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Termaat R. M., Assmann K. J., Dijkman H. B., van Gompel F., Smeenk R. J., Berden J. H. Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms. Kidney Int. 1992 Dec;42(6):1363–1371. doi: 10.1038/ki.1992.428. [DOI] [PubMed] [Google Scholar]
  21. Vlahakos D. V., Foster M. H., Adams S., Katz M., Ucci A. A., Barrett K. J., Datta S. K., Madaio M. P. Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int. 1992 Jun;41(6):1690–1700. doi: 10.1038/ki.1992.242. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES